BIO-MEDICAL SCIENCE WORLD Corporation latest cancer research Biotechnology
Maximo A. Benavides MD , MSc :.
BIO-MEDICAL SCIENCE WORLD Corporation latest cancer research Biotechnology
Maximo A. Benavides MD , MSc :.
Bio-Medical Science World Corp.
Our Compromise with Humankind
We seek to cure cancer. We understand that a significant challenge is the impenetrable nature of the cancer cell membrane, blocking many compounds and chemotherapies. In this era of selective treatment, we aim to target cancer cells while avoiding harm to benign cells.
We will help identify how amino acid analogs enter the cancer cell and inactivate growth and proliferation at various cellular levels without damaging the remainder of the cell and how this is a reversible mechanism that does not affect benign cells. We will pursue this goal with more than a decade of experience contributing directly to identifying the mechanism and proposing treatments that target cancer cells.
We will develop patents and products in several areas of biotechnology: 1. cancer treatment, 2. cancer biomarkers, 3. ELISA tests for cancer, 4. cancer immunotherapy via antibodies, 5. mRNA vaccines for cancer and viruses, and 6. drug discovery.
"My dream as a child was to heal person by person. Today's dream is to heal humanity."
Maximo A. Benavides, MD, MSc :.
CEO & Founder
19:24 Genesis
כד וַיהוֶה הִמְטִיר עַל סְדֹם וְעַל עֲמֹרָה גָּפְרִית וָאֵשׁ מֵאֵת יַהוֶה מִן הַשָּׁמָיִם
"Then the LORD rained down fire and burning sulfur from the sky on ......."
Publications
Scientific News
- Select Publications
Benavides, M. A. (2022). L-Methionine may modulate the assembly of SARS-CoV-2 by interfering with the mechanism of RNA polymerase. Medical Hypotheses, 161, 110798. https://doi.org/10.1016/j.mehy.2022.110798
Benavides, M. A. (2022). Novel inhibitors of the disulfide/methyl-ATP pump inhibit the proliferation of cancer cells: Analogs of methionine. Medical Hypotheses, 158, 110743. https://doi.org/10.1016/j.mehy.2021.110743
Benavides, M. A., et al. (2014). L-Methionine inhibits growth of human pancreatic cancer cells. Anti-Cancer Drugs, 25, 200–203. https://doi.org/10.1097/CAD.0000000000000038
Benavides, M. A., et al. (2011). L-Methionine-induced molecular signatures in MCF-7 and LNCaP cancer cells. Journal of Cancer Research and Clinical Oncology, 137(3), 441–453. https://doi.org/10.1007/s00432-010-0897-5
Benavides, M. A., et al. (2010). Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cancer cells but not in non-tumorigenic epithelial cells. Anti-Cancer Research, 30, 1881–1886. https://ar.iiarjournals.org/content/30/6/1881.long
Benavides, M. A., et al. (2007). Methionine inhibits cellular growth depending on p53 status. American Journal of Surgery, 193, 274–283. https://doi.org/10.1016/j.amjsurg.2006.07.016
- Patents
Benavides, M. A. (2022). Inhibitor of S=/CH₃-ATP Pump in cancer cells: L-methionine and analogs of methionine.
U.S. Provisional Patent Application No. 63/294,913. (Cancer Therapy)
Benavides, M. A. (2022). Analogs of sulfur amino acids identify an antiviral target for vaccines and antiviral therapy.
U.S. Provisional Patent Application No. 63/261,749.